Robertson Stephens Wealth Management LLC Has $400,000 Stake in Intuitive Surgical, Inc. $ISRG

Key Points

• Robertson Stephens Wealth Management LLC reduced its holdings in Intuitive Surgical, Inc. by 64.5%, now owning 736 shares worth $400,000.
• Intuitive Surgical's recent quarterly earnings report indicated an earnings per share (EPS) of $2.19, surpassing estimates, with revenue growth of 21.4% year-over-year.
• Insider selling has been significant, with VP Myriam Curet selling 4,500 shares and insider Gary S. Guthart selling 29,360 shares in recent months.

Robertson Stephens Wealth Management LLC decreased its holdings in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) by 64.5% in the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The institutional investor owned 736 shares of the medical equipment provider's stock after selling 1,337 shares during the quarter. Robertson Stephens Wealth Management LLC's holdings in Intuitive Surgical were worth $400,000 at the end of the most recent quarter.

Several other institutional investors have also recently bought and sold shares of ISRG. Chilton Capital Management LLC raised its stake in Intuitive Surgical by 614.3% during the first quarter. Chilton Capital Management LLC now owns 50 shares of the medical equipment provider's stock worth $25,000 after acquiring an additional 43 shares in the last quarter. Elite Financial Inc. acquired a new position in Intuitive Surgical during the first quarter worth about $26,000. LFA Lugano Financial Advisors SA acquired a new position in Intuitive Surgical during the first quarter worth about $30,000. TD Capital Management LLC raised its stake in Intuitive Surgical by 300.0% during the first quarter. TD Capital Management LLC now owns 60 shares of the medical equipment provider's stock worth $30,000 after acquiring an additional 45 shares in the last quarter. Finally, 1248 Management LLC bought a new stake in shares of Intuitive Surgical during the first quarter worth about $30,000. Institutional investors and hedge funds own 83.64% of the company's stock.

Intuitive Surgical Price Performance

Shares of ISRG stock opened at $429.59 on Friday. The business's 50 day simple moving average is $458.68 and its 200 day simple moving average is $497.91. Intuitive Surgical, Inc. has a one year low of $425.00 and a one year high of $616.00. The stock has a market capitalization of $154.00 billion, a PE ratio of 59.91, a PEG ratio of 4.51 and a beta of 1.61.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last issued its quarterly earnings results on Tuesday, July 22nd. The medical equipment provider reported $2.19 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.93 by $0.26. Intuitive Surgical had a return on equity of 14.56% and a net margin of 28.51%.The firm had revenue of $2.44 billion for the quarter, compared to analyst estimates of $2.35 billion. During the same period in the previous year, the firm earned $1.78 earnings per share. The company's revenue was up 21.4% compared to the same quarter last year. As a group, research analysts expect that Intuitive Surgical, Inc. will post 6.43 earnings per share for the current year.

Insider Buying and Selling at Intuitive Surgical

In other Intuitive Surgical news, EVP Myriam Curet sold 4,500 shares of the business's stock in a transaction that occurred on Friday, July 25th. The stock was sold at an average price of $492.48, for a total value of $2,216,160.00. Following the transaction, the executive vice president directly owned 353 shares of the company's stock, valued at approximately $173,845.44. The trade was a 92.73% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this hyperlink. Also, insider Gary S. Guthart sold 29,360 shares of the business's stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $472.49, for a total value of $13,872,306.40. Following the completion of the transaction, the insider directly owned 19,827 shares in the company, valued at approximately $9,368,059.23. This trade represents a 59.69% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last three months, insiders have sold 45,224 shares of company stock valued at $21,716,492. 0.70% of the stock is currently owned by company insiders.

Analyst Upgrades and Downgrades

ISRG has been the topic of several research reports. Zacks Research cut Intuitive Surgical from a "strong-buy" rating to a "hold" rating in a report on Wednesday, August 20th. Truist Financial boosted their price target on Intuitive Surgical from $590.00 to $600.00 and gave the stock a "buy" rating in a report on Wednesday, July 23rd. Wells Fargo & Company boosted their price target on Intuitive Surgical from $559.00 to $599.00 and gave the stock an "overweight" rating in a report on Wednesday, July 23rd. The Goldman Sachs Group reduced their price target on Intuitive Surgical from $621.00 to $567.00 and set a "buy" rating on the stock in a report on Wednesday, October 1st. Finally, Deutsche Bank Aktiengesellschaft restated a "sell" rating on shares of Intuitive Surgical in a report on Friday, August 22nd. Fourteen research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock presently has a consensus rating of "Moderate Buy" and an average price target of $589.43.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.